Ascendis Pharma A/S American Depositary Shares
ASND Real Time Price USDRecent trades of ASND by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ASND's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
Estimated quarterly lobbying spending
ASND Revenue by Segment or Geography
New patents grants
-
Patent Title: Auto injector with variable plunger force Mar. 18, 2025
-
Patent Title: Hydrogel cross-linked hyaluronic acid prodrug compositions and methods Mar. 11, 2025
-
Patent Title: Auto injector with adaptable air-shot mechanism Feb. 18, 2025
-
Patent Title: Auto injector with detection of used cartridge and associated method Jun. 11, 2024
-
Patent Title: Auto injector with adaptable air-shot mechanism Apr. 30, 2024
-
Patent Title: Auto injector with reconstitution handling support Apr. 16, 2024
-
Patent Title: Conjugation method for carrier-linked prodrugs Feb. 13, 2024
-
Patent Title: Auto injector with charger safety Aug. 29, 2023
-
Patent Title: Auto injector with variable plunger force Jun. 27, 2023
-
Patent Title: Hydrogel cross-linked hyaluronic acid prodrug compositions and methods May. 09, 2023
-
Patent Title: Prodrugs comprising an aminoalkyl glycine linker Apr. 25, 2023
-
Patent Title: Front loaded auto injector for administering a medicament Mar. 21, 2023
-
Patent Title: Biodegradable polyethylene glycol based water-insoluble hydrogels Jan. 24, 2023
-
Patent Title: Auto injector with cartridge locking system Dec. 13, 2022
-
Patent Title: Auto injector with adaptable air-shot mechanism Dec. 06, 2022
-
Patent Title: Auto injector with charger safety Aug. 09, 2022
-
Patent Title: Auto injector with temperature control Jun. 07, 2022
-
Patent Title: Prodrugs comprising a pyroglutamate linker Apr. 12, 2022
-
Patent Title: Auto injector with detection of used cartridge and associated method Nov. 23, 2021
-
Patent Title: Hydrogel-linked prodrugs releasing tagged drugs Sep. 14, 2021
-
Patent Title: Diagnosis, prevention and treatment of diseases of the joint Apr. 20, 2021
-
Patent Title: Injector Jan. 12, 2021
-
Patent Title: Auto injector with cartridge retention system Nov. 17, 2020
-
Patent Title: Carrier-linked treprostinil prodrugs Aug. 04, 2020
-
Patent Title: Hydrogel-linked prodrugs releasing tagged drugs May. 19, 2020
-
Patent Title: Protecting group comprising a purification tag Aug. 07, 2018
-
Patent Title: Hydrogel formulations Jul. 24, 2018
-
Patent Title: Carrier-linked prostanoid prodrugs Mar. 13, 2018
-
Patent Title: Sustained release composition of prostacyclin Jan. 23, 2018
-
Patent Title: Hydrogel prodrugs Jan. 02, 2018
-
Patent Title: Carrier-linked treprostinil prodrugs Feb. 07, 2017
-
Patent Title: Carrier-linked carbamate prodrug linkers Feb. 07, 2017
-
Patent Title: Dipeptide-based prodrug linkers for aliphatic amine-containing drugs Jan. 03, 2017
-
Patent Title: Sterilization of biodegradable hydrogels Mar. 08, 2016
-
Patent Title: Prodrugs containing an aromatic amine connected by an amido bond to a linker Nov. 03, 2015
-
Patent Title: Dipeptide-based prodrug linkers for aliphatic amine-containing drugs Jun. 23, 2015
-
Patent Title: Hydrogel formulations Jun. 16, 2015
-
Patent Title: Sterilization of biodegradable hydrogels Mar. 24, 2015
-
Patent Title: Prodrug comprising a drug linker conjugate Dec. 09, 2014
-
Patent Title: Subcutaneous paliperidone composition Jun. 24, 2014
-
Patent Title: Hydrogel formulations Jun. 28, 2011
-
Patent Title: Protein-proteophore complexes Feb. 01, 2011
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to ASND
Recent picks made for ASND stock on CNBC
ETFs with the largest estimated holdings in ASND
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $ASND stock a Buy, Sell, or Hold?
- What is the price target for $ASND stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $ASND stock?
- Who owns the most shares of $ASND stock?
- What funds own $ASND stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ASND Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.